Journal article
Molecular Evolution of Respiratory Syncytial Virus Fusion Gene, Canada, 2006–2010 - Volume 18, Number 1—January 2012 - Emerging Infectious Diseases journal - CDC
Abstract
To assess molecular evolution of the respiratory syncytial virus (RSV) fusion gene, we analyzed RSV-positive specimens from 123 children in Canada who did or did not receive RSV immunoprophylaxis (palivizumab) during 2006-2010. Resistance-conferring mutations within the palivizumab binding site occurred in 8.7% of palivizumab recipients and none of the nonrecipients.
Authors
Papenburg J; Carbonneau J; Hamelin M-È; Isabel S; Bouhy X; Ohoumanne N; Déry P; Paes BA; Corbeil J; Bergeron MG
Journal
Emerging Infectious Diseases, Vol. 18, No. 1, pp. 120–124
Publisher
Centers for Disease Control and Prevention (CDC)
Publication Date
January 2012
DOI
10.3201/eid1801.110515
ISSN
1080-6040